HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV

Autores/as

  • Alejandra Jalil Portillo-Romero Instituto Nacional de Salud Pública
  • Leith León-Maldonado Instituto Nacional de Salud Pública
  • Betania Allen-Leigh Instituto Nacional de Salud Pública
  • Brandon Brown School of Medicine, University of California at Riverside
  • Carlos Magis CENSIDA
  • Norma Beatríz García-Fuentes Coordinación Estatal del Programa de VIH, SIDA e ITS, Servicios de Salud de Morelos
  • Jorge Salmerón Unidad Académica en Investigación Epidemiológica, Centro de Investigación de Políticas de Población y Salud, Facultad de Medicina, Universidad Nacional Autónoma de México,
  • Erika Hurtado Instituto Nacional de Salud Pública
  • Leticia Torres-Ibarra Instituto Nacional de Salud Pública
  • Berenice Rivera-Paredez Instituto Nacional de Salud Pública
  • Rubí Hernández-López Instituto Nacional de Salud Pública
  • Elsa Yunes-Díaz Instituto Nacional de Salud Pública
  • Eduardo Lazcano-Ponce Instituto Nacional de Salud Pública

DOI:

https://doi.org/10.21149/10182

Palabras clave:

HPV vaccine, acceptability, people living with HIV, women, male

Resumen

Materials and methods. A total of 1 329 men and women, with and without HIV, participated in one of three intervention studies, offering HPV vaccination, carried out in the states of Morelos, Tlaxcala and Mexico City; either the bivalent (Morelos n=103, Tlaxcala n=127) or quadrivalent HPV-vaccine (Mexico City n=1 099) was offered. Results. HPV vaccine was accepted by 80.3% of participants; acceptance was higher in people living with HIV than those without (84.4 vs. 78%, p=0.004). Women had greater HPV infection knowledge (p<0.0001) than men and slightly higher (p=0.4) vaccine acceptance. The main reason for vaccine non-acceptance among HIV-positive participants was their doctor recommended they not get vaccinated. Conclusion. Acceptance of HPV-vaccine was high in men and women regardless of HIV status. Even higher rates of acceptability may be achieved by educating healthcare providers to recommend HPV vaccine to their patients.

Descargas

Los datos de descargas todavía no están disponibles.

Descargas

Publicado

2018-12-13

Cómo citar

1.
Portillo-Romero AJ, León-Maldonado L, Allen-Leigh B, Brown B, Magis C, García-Fuentes NB, Salmerón J, Hurtado E, Torres-Ibarra L, Rivera-Paredez B, Hernández-López R, Yunes-Díaz E, Lazcano-Ponce E. HPV vaccine acceptance is high among adults in Mexico, particularly in people living with HIV. Salud Publica Mex [Internet]. 13 de diciembre de 2018 [citado 5 de junio de 2024];60(6, nov-dic):658-65. Disponible en: https://saludpublica.mx/index.php/spm/article/view/10182

Artículos más leídos del mismo autor/a

1 2 3 4 5 6 7 8 9 10 > >>